Skip to main content
PLOS One logoLink to PLOS One
. 2021 Apr 13;16(4):e0249620. doi: 10.1371/journal.pone.0249620

The internal realities of individuals with type 2 diabetes–Psychological disposition in self-management behaviour via grounded theory approach

Yogarabindranath Swarna Nantha 1,2,*, Azriel Abisheg Paul Chelliah 3, Shamsul Haque 2, Anuar Zaini Md Zain 1
Editor: Nelly Oelke4
PMCID: PMC8043383  PMID: 33848301

Abstract

Background

A paradigm shift in the disease management of type 2 diabetes is urgently needed to stem the escalating trends seen worldwide. A “glucocentric” approach to diabetes management is no longer considered a viable option. Qualitative strategies have the potential to unearth the internal psychological attributes seen in people living with diabetes that are crucial to the sustenance of self-management behaviour. This study aims to identify and categorize the innate psychological dispositions seen in people with type 2 diabetes in relation to self-management behaviour.

Methods

We adopted a grounded theory approach to guide in-depth interviews of individuals with type 2 diabetes and healthcare professionals (HCP) at a regional primary care clinic in Malaysia. Twenty-four people with type 2 diabetes and 10 HCPs were recruited into the study to examine the inner narratives about disease management. Two focus group discussions (FGD) were also conducted for data triangulation.

Results

Participants’ internal dialogue about the management of their disease is characterized by 2 major processes– 1) positive disposition and 2) negative disposition. Optimism, insight, and awareness are important positive values that influence T2D self-care practices. On the other hand, constructs such as stigma, worries, reservations, and pessimism connote negative dispositions that undermine the motivation to follow through disease management in individuals with type 2 diabetes.

Conclusions

We identified a contrasting spectrum of both constructive and undesirable behavioural factors that influence the ‘internal environment’ of people with type 2 diabetes. These results coincide with the constructs presented in other well-established health belief theories that could lead to novel behavioural change interventions. Furthermore, these findings allow the implementation of psychosocial changes that are in line with cultural sensitivities and societal norms seen in a specific community.

Introduction

Type 2 diabetes (T2D) represents greater than 90% of all diabetes subtypes, and a significant percentage of this is preventable [1]. Nevertheless, there continues to be an unabated rise in the rates of T2D worldwide over the past 2 decades [1]. By the year 2015, approximately 451 million people were afflicted by T2D globally [2, 3]. These figures dramatically surpass the modest projection made by World Health Organization (WHO) for the year 2030 by almost 2 fold [4]. The burden of T2D has incurred a tremendous strain on the national budget of many countries, prompting experts to declare T2D as a pandemic of global proportions [5].

Judging from the lacklustre trends seen in disease management spanning across the last 2 decades, a “glucocentric” approach is no longer considered a viable option in the elusive battle to turn the tides against the escalating trends of T2D seen throughout the world [5]. Studies have shown that the recommended targets for hemoglobin A1c (HbA1c) levels cannot be achieved through an arsenal of pharmacological treatments alone [6]. Instead, the effective management of T2D requires healthcare professionals (HCP) to customize an individualized strategy for each individual with T2D [2, 5, 7]. At the heart of this strategy is the sustenance of self-management practices that rely profoundly on our clear understanding of the unarticulated thought processes that define the typical behaviour of a person living with T2D.

The findings from the Disease, Attitudes, Wishes, and Needs Second study (DAWN2) suggest that the inner wellbeing of people with T2D plays an integral role in the determination of their prospective health outcome [8]. Studies also indicate optimal self-management practices are highly dependent on the effective communication between persons with T2D and their HCPs [9, 10]. In line with this postulation, there is an overwhelming consensus that HCPs should ideally be equipped with a tacit understanding of the wishes and needs of individuals with T2D [8]. Therefore, high-quality diabetes care hinges on the ability to fill the gap between research and practice by identifying the psychological needs of people with T2D.

This paper aims to expound on the self-management patterns in people with T2D closely related to an integrated behavioural model proposed in a previously published protocol [11]. Using a grounded theory approach, we aim to identify the essential drivers of self-management attitudes by exploring the internal psychological aspects that characterize the mindset of people with T2D in relation to their disease. We also intend to classify these dispositional traits of individuals with T2D into a functional behavioural model that is amenable to empirical quantitative testing [11].

Material and methods

Design

Detailed behavioural patterns pertinent to the objectives of this study were elucidated via a qualitative inquiry strategy. Consequently, we employed an inductive approach to 1) discover the inner psychological disposition of individuals with T2D, 2) decipher and modify inferences based on emergent data, 3) use theory-building techniques as the foundation to draw newer insights other than those documented in literature. A maximum variation sampling strategy was used to achieve a diverse sample that corresponds to sociodemographic and disease control indicators (Tables 1 and 2) [11]. Moreover, theoretical sampling was utilized to identify information-rich cases to strengthen the validity of emergent constructs that explain self-management behaviour in persons with T2D. This study received approval from the Medical Research and Ethics Committee, Ministry of Health Malaysia (NMRR-18-151-39886) on the 30th of May 2018, and Monash University Human Research Ethics Committee on the 10th of October 2018 (Project ID: 17062).

Table 1. Demographic details of T2D patients of the study.

Subject Characteristics N
Gender
Male 15
Female 9
Age In Years
< 30 <5
31–50 6
51–60 7
61–70 7
> 70 <5
Ethnicity
Malay 12
Chinese <5
Indian 10
Others <5
Marital Status
Unmarried <5
Married 19
Divorced <5
Widow/Widower <5
Work Status
Not working 12
Working Full-time 8
Working Part-time <5
Self-employed <5
Level Of Education
Certificate level 19
Diploma <5
Bachelor’s degree <5
Diabetes duration (years)
< 5 5
6–10 <5
11–15 5
16–20 <5
> 21 <5
Number of medications
3–5 12
> 6 12
Type of medication
Oral only 5
Insulin only <5
Combination 15
Glycaemic status
6.5–8.0% <5
8.1–9.0% 9
9.1–10% 5
> 10% 8
Complications
No 17
Yes 7
Number of comorbidities
1 13
2 <5
> 3 8

Table 2. Demographic details of healthcare professionals involved in the study.

Subject Characteristics N
Profession
Diabetic educator (nurse) 5
GPs <5
Pharmacists <5
Mean Age In Years 34
Mean Years In Service 10
Ethnicity
Malay 7
Chinese <5
Indian <5
Marital Status
Unmarried <5
Married 7
Divorced <5
Level Of Education
Diploma <5
Bachelor’s degree 5
Master’s degree <5

Participants and setting

Individuals with T2D were recruited through a purposive sampling method from the non-communicable disease department at the Seremban Primary Care centre, a regional multidisciplinary general practice clinic within the state of Negeri Sembilan, Malaysia. The process of enrollment into this project took place between May 2018 to April 2019. The inclusion criteria for people with T2D to take part in the study are as follows: 1) above the age of 18, 2) fluent in both English and Malay language, 3) evidence of a diagnosis of T2D in their case history, and 4) received followed-up at the clinic for at least 2 years [11]. The principal investigator is tasked with describing the details of the study to all individuals with T2D during their routine medical consultation at the clinic. HCPs comprised of GPs, diabetic educators (nurses), and pharmacists were also invited to join the study. Then, we obtained written consent and permission from all participants to audio record the interview sessions. Subsequently, all participants were given an appointment to attend a scheduled interview session. The demographic details of all the participants involved in this study are outlined in Tables 1 and 2.

Data collection

Thirty-four individuals with T2D and 14 HCPs were invited to participate in the study. Four HCP declined participation, while 10 T2D people did not respond to our invitation. Ultimately, 24 people with T2D (in-depth interviews) and 10 HCPs (key-informant interviews) joined this study. Each interview lasted between 75 to 90 minutes. Once the formal coding process was complete for all the transcripts derived from the in-depth interviews, 2 FGDs (8 people with T2D in each session, each session lasting approximately 90 minutes) were conducted as part of the data triangulation process.

All participants were interviewed in a room within the confines of the clinic that was specifically allotted for the purpose of this study. In-depth interviews were guided by research questions (compiled in the form of a topic guide; S1 File) designed to assess the inherent psychological attributes closely associated with self-management behaviour in persons with T2D [11]. Steps were also taken to ensure these interviews remained unstructured enough to discover novel concepts and ideas. Moreover, the topic guide was updated continuously in tandem with the acquisition of newer themes from these interviews. A detailed description of this process is summarized in a flowchart in S1 Fig.

After the 10th round of interviews, the interviews did not uncover newer themes and theoretical saturation was considered to have been achieved. The validity of the emergent narratives from these themes was explored, reinforced, and finalized via additional interviews with 14 individuals with T2D. The interviews were audiotaped and transcribed verbatim. Field notes were made in the form of memoing during and after the interviews. One researcher (YSN) conducted all interviews.

Data management and analysis

Proofread transcripts were then entered into a qualitative software (Atlas.TI qualitative analysis program, Version 7, Cincorn Systems Inc, 2008 [to code of transcripts and generate themes]; NVivo Plus, Version 12, QSR International, 2019 [to determine inter-coder and content consistency]) and coded manually to identify specific concepts. The data were coded in accordance with the classical and constructivist Grounded Theory methods [12, 13].

All transcripts were coded independently (S1 Table). A list of emerging themes and categories was then generated by the primary researcher (YSN). Subsequently, two independent coders scrutinized and coded the transcripts for categories, themes, and sub-themes. An excellent inter-coder consistency was found (Cohen’s κ = 0.84). Disagreements were resolved via discussions. Similarly, the themes derived from this study were assessed by a panel of experts and showed excellent content consistency (Cohen’s κ = 0.88).

Trustworthiness

This study’s trustworthiness was enhanced by using multiple data collection techniques (S1 Fig; S1 Table) such as in-depth interviews and FGDs (methodological triangulation) [14]. Two researchers were involved in data analysis and interpretation (investigator triangulation). Different sources (people with T2D and HCPs) of the same information were used to validate data (data triangulation and negative case analysis). The authors repeatedly analyzed, theorized, and revised concepts at various stages of the study (persistent observation).

Results

In our study, the internal psychological reality of individuals with T2D can be summarized into two main constructs– 1) positive disposition and 2) negative disposition. There appears to be a dynamic interaction between these constructs and numerous other concepts shown in Fig 1 –the factors associated with the external reality and the mediators of optimal behavior create the tapestry for the workings of the internal realities seen in our participants. The balance between an array of personal dispositional qualities appears to determine compliance with self-management behaviour (Fig 1, Table 3, S1 Table).

Fig 1. Conceptual framework describing the external reality, internal reality and mediators related to self-management of T2D.

Fig 1

Table 3. Categories, definitions, frequency, and codes describing the personal disposition of individuals with T2D.

Category Sub-category Frequency Codes
Positive Insight 285 Clarity about the role of insulin
disposition Taking charge of health
Understanding the need for medications
Positive innate Knowing the nature of disease
qualities of the Optimism 260 Attitude towards medication
mind and Attitude towards disease
character Innate attitude
Awareness 200 Specific knowledge about disease
Diet and exercise
Acceptance 88 Accepting illness
Accepting the need to take medications
Vigilance 43 Being cautious
Positivity 42 Having the right mindset
Appreciating the value of life
Coping 50 Being true to self
mechanism Positive thoughts
Being spiritual
Negative Reservation 181 Negativity about having the disease
disposition Reluctance to use medication
Issues with medication compliance
Negative Relationship with doctor
innate qualities Worries 174 Effects of complications on life
of the mind and Fearing complications
character Concerns about medications
Concerns about illness
Concerns over the behaviour of doctors
Stigma 141 Discrimination
Avoidance
Pessimism 130 Unhelpful thoughts about taking
medications
Unwarranted 55 Curability of disease
optimism Violations in dietary restrictions
Medication avoidance
Denial 36 Unwilling to accept reality

Positive disposition

Optimism and positivity

Our study demonstrates that participants with T2D who appreciate the value of being alive also “wish to live longer” and frequently express gratefulness for not having developed any complications related to their disease. Similarly, information from the FGDs conducted in this study indicates that most T2D participants believe that a right “mental attitude” spurs better self-management practices. For example, several participants with T2D feel that they should first start by “being honest with themselves” if they sincerely wish to embody the habits that come hand-in-hand with optimal self-care practices.

“If there is a problem with their attitude [towards the disease] then everything will take a turn for the worse. So, it depends on their attitude and how they see the sickness in themselves.”

(64, Female)

“I want to be honest to myself for the sake of my health. Only then I can certain I will not fail or miss taking my medications.” (60, Male)

Many individuals with T2D interviewed in our study adopt a strongly positive attitude towards their disease to the degree that they “feel healthy” despite having T2D. Most of them express indifference about being diagnosed with T2D and remain convinced that they can effectively manage their illness. They are confident about being well-equipped with the information required for appropriate disease management, especially in relation to medication compliance.

Many T2D participants display a favourable attitude towards modern medicine and express little hesitation about consuming medications. They also claim it takes minimal effort to comply with the recommended medication timings suggested by their general practitioner (GP) and pharmacist. Generally, insulin users in our study have positive views about using injectables and dismiss injecting insulin as being painful. These beliefs are primarily driven by the optimism that disease-related complications can be fully averted by being compliant with medications.

“I believe ‘Western’[allopathic] medications work very fast in bringing down sugar levels. For me, ‘Western’ medications are important because you can see from research results that science has progressed really far.” (52, Male)

“Definitely no [developing complications] doctor. If I take my medications accordingly and follow the advice of the doctors, I foresee no problems.” (42, Male)

Acceptance

HCPs such as GPs, pharmacists, and nurses confess that it takes time for participants with T2D to grasp that they need to live with T2D for the rest of their lives. Grappling with the immediacy of reality, they eventually accept the idea that T2D has occurred in them with a sense of partial resignation. They profess they have “come to terms” with the realities of their disease. They quickly move on to develop the mental fortitude required to cope with the sudden changes to their ordinary way of living.

“At the end of the day, you have to overcome it yourself. You need to reach some kind of understanding. First, you have to come to terms with yourself. Look, you have diabetes and you’ve got this sickness. So the only way to make you better is to stick with your medications.” (44, Male)

With the passage of time, we found that the acceptance of their disease cultivates better medication compliance in T2D participants. They no longer struggle with the initial ambivalence related to frequent medication non-adherence. They become unperturbed about taking medication in the presence of others (especially injecting insulin) and easily conquer the initial fear associated with insulin utilization.

“I remember being late one day, I had to stop by at the petrol station. I got out [of the car] and started to use my insulin. A few of my friends were coincidentally there too. They asked me ‘what’s this?’ and I answered [nonchalantly] ‘well it’s insulin’. So no worries there.” (59, Male)

Insight

Participants with T2D perceive diabetes as a chronic disease that can only be controlled and will “always remain in our blood”. They consider the presence of physical symptoms an unreliable indicator of poor T2D control partly because these warning signs remain imperceptible while having high blood glucose levels. Therefore, they often yearn to control their disease better, knowing full well complications can occur due to poorly controlled blood glucose levels.

T2D participants place a high degree of faith in the efficacy of medications prescribed to them; some even confess that “it will really bring down your sugar levels”. They are acutely aware of the dangers of non-compliance and realize that it is imperative to consume medications as advised. Additionally, they believe that taking medication in accordance with the recommended timing schedule does play a crucial role in stabilizing blood glucose levels.

Individuals with T2D in our study believe insulin is a far potent alternative when compared to oral medication and clearly indicate a greater preference for insulin over oral medications. They also often become more receptive to the idea of insulin commencement once their GPs successfully convince them to do so.

“Why should I take insulin? And then one day came along this doctor, advising me that it is good for me. Now I feel healthier [after starting insulin]” (70, Male)

As far as lifestyle modification is concerned, most T2D participants find the adherence to dietary restrictions burdensome only at the preliminary phase of their disease. Moreover, they believe these dietary measures are critical to the long-term control of T2D.

“Initially, when I was told to control my diet, I thought it was missing it all [food]. But that was only in the beginning. Soon, I became accustomed to it.” (60, Male)

“You see, everything you consume will affect your sugar levels. You have to understand that. So there is a limit to everything. If you don’t control it [food], your sugar levels will increase”. (52, Male)

Awareness

From our interviews, having adequate knowledge about the disease fosters better awareness in T2D participants, which in turn closely mediates the “willpower to change themselves”. Therefore, well-informed T2D participants acknowledge that optimal disease control requires both medication compliance and the sustenance of therapeutic lifestyle changes in equal measure. They believe that it is necessary to consume lifelong medications despite having learned medications can, at times, cause certain undesirable side effects.

Participants with T2D recognize the importance of following appropriate dietary measures to manage their disease and often attribute uncontrolled blood glucose levels to poor dietary habits. They are cognizant of the types of food that are suitable for consumption in individuals living with T2D. For example, the intake of refined sugar is considered “dangerous”. Therefore, most interviewees with T2D squarely blame the overconsumption of sugar (e.g. drinking sugary beverages) as the principal cause of T2D. They believe that an indulgent lifestyle (lacking both dietary restraint and adequate exercise) is most likely the root cause for having acquired T2D in the first place.

“For me, diabetes is self-inflicted. Because I feel that in the past, I did certain things that might have caused me to have this disease. My parents never had diabetes. I am a diabetic because I did not have restraint over the food that I consumed.” (61, Male)

Additionally, participants with T2D are highly conscious of the need for adequate physical exercise and how it could potentially help achieve better control of their disease. Many T2D interviewees believe that exercising can work as an adjunct to reducing blood glucose levels in their bodies.

“It doesn’t matter what my sugar levels might be, I will do exercise and look after my diet so that I will not experience any complications” (80, Male)

“I love to exercise; it will bring down sugar levels in our body” (65, Female)

Vigilance

Participants with T2D acknowledge that diabetes is a disease that should not be taken lightly. During FGDs, these individuals state that they remain in a state of constant vigilance—they are “more careful” and watchful for any T2D related complications. They also tend to be mindful of recommended lifestyle changes such as exercise and dietary recommendations. They frequently investigate fluctuations in their blood glucose levels using glucometers at home.

“From what I know, diabetes is a serious sickness for me. You need to take good care of yourself to overcome this sickness.” (59, Male)

Coping mechanism

Most participants with T2D believe that God determines their destiny and, by default, the progress of their disease. They rely on God to provide deliverance from any anxiety that stems from the inner insecurities about the nature of their disease. Some T2D people go so far as to adopt a ‘man proposes, God disposes’ ideology.

“I leave that [the way the disease progresses] to God. You do your part and ultimately God decides.” (70, Male)

More secular-minded T2D participants resort to thought avoidance techniques to negate negative narratives about the prospects of their disease. These T2D participants also view life as being impermanent. As a consequence, they embrace uncertainty and live life as determined by fate.

“Talking about kidney-related complications and all that, you know, there are many things in this world that are basically unknown doctor. Nothing is certain in life.” (42, Female)

Negative disposition

Denial

Nearly half of the participants with T2D in this study expressed initial difficulty accepting the diagnosis of T2D. This state of denial was reinforced by assuming that being previously “active” (due to the nature of work or engaging in sports activities) should have prevented T2D.

“I couldn’t accept reality [diagnosed with T2D]. I felt I could just go on with my life as usual. I made sure I did more exercise. I still indulged in food.” (52, Male)

“I should not have been diagnosed with diabetes. I was an athlete, so I believe I should not have this disease. I did all sorts of exercise activities. Why does this have to happen to me?” (60, Male)

Pessimism

Many participants with T2D feel depressed about having contracted diabetes. The abruptness in the demands for sudden lifestyle modifications imposes “too much restriction” to the conventional way of going about with their lives. This situation affects their emotions in such a way that some of these individuals think that it’s not worth living any longer. This notion is especially true if they have to endure any complications as a result of their disease. After a protracted period of time, some of them descend into helplessness characterized by low morale or a “giving up” mentality. On the other hand, a small group of T2D participants remain relatively untroubled as they have surrendered to the notion that everyone will develop T2D at some point in their lives.

“Why try so hard and control it [T2D]? Just enjoy life as it is. One way or another, you will definitely end up getting diabetes. You just need to take your medications. Life goes on.” (65, Male)

The frustration of taking medications all their lives appears to dominate the thoughts of most T2D participants. They describe getting fed up with taking medication all the time and wanting to “give it a break” by going on occasional ‘drug holidays’. Most importantly, they perceive taking more medications is synonymous with the deterioration in their general health status.

“When they told me that I really need to take medication for the rest of my life, my heart literally skipped a beat. I was totally upset. I really dislike taking medications.” (53, Female)

“Sometimes you feel like ‘it’s ok, you don’t need to take it today, just give your body a rest’. It’s that kind of feeling.” (28, Female)

Reservations

There appears to be an initial reluctance on the part of interviewees with T2D to start taking T2D medications early. GPs reveal that they receive frequent requests from T2D people to delay the commencement of T2D medications. This avoidant behaviour becomes even more apparent when GPs suggest the introduction of insulin into their medication regime. They vehemently dismiss the need for insulin by reiterating they prefer oral medications instead. Much later, when the stark realization sets in, participants with T2D slowly realize they now “have no choice” but to take their medications as advocated by HCPs.

“But I have this sickness, I don’t really have a choice. We have got to take our medications. What else can I do? We have no choice but to take our medications” (65, Female)

Compliance with medications does not appear to be an obstacle in the early stages of the disease. However, participants with T2D gradually develop conflicting thoughts about adhering to medications after a few months of living with diabetes. One prime reason for this is their constant preoccupation with the side effects of medications. Consequently, many of these individuals tend to skip their medications when side effects arise without soliciting the advice of their GPs. These adverse reactions cause an aversion to medications to which T2D participants respond by first doubting the efficacy of T2D medications and then skipping their medications altogether.

“I have already taken my medications you know. But it still doesn’t go down [blood glucose levels]. That’s when I think to myself, how could this happen? That’s why I skip my medications sometimes.” (42, Male)

Our interviews brought to light several problem areas that appear to undermine optimal doctor-patient relationships during routine clinical consultations. Among others, participants with T2D often hesitate to consult GPs about any concerns about their disease out of the fear of being reprimanded. They are also reluctant to accept their GP’s decision to modify the dosage of their current medications. Participants with T2D interpret this as a deliberate attempt at prematurely increasing the dosage of their medications.

“They [individuals with T2D] are afraid to ask anything. The doctor might turn around and say ‘who is the doctor now?’. I have experienced that before. So they [individuals with T2D] don’t want to get hurt. And that’s the reason why don’t want to ask [questions].” (64, Female)

“What they [GP] recommend you take once a day has now become twice a day. From twice a day, it becomes thrice a day. So, that’s the problem. That’s why I dislike taking medicine. There’s no end to it.” (65, Male)

Worries

Participants with T2D worry about developing T2D related complications (renal impairment, heart disease, and amputations) in the near future. Above all, they dread acquiring any form of kidney impairment as a result of their condition. They do not wish to lead a life fraught with complications as it considerably reduces their quality of life. The slightest deviation in their wellbeing (e.g., the presence of uncontrolled blood glucose levels) heightens the state of fear that they might succumb to complications. Hence, this behavior engenders a belief system where participants with T2D perceive that there is a significant risk of developing complications if they do not take medications as instructed by HCPs.

“I have to take my medications, I am worried that something would happen to me. I could get a stroke or they might amputate my leg. That’s what I am worried about” (75, Female)

Participants with T2D worry about immediate and long-term harm medications can apparently inflict on their body. A small proportion of these individuals feel uneasy about the idea of using insulin needles out of the fear of pain. Interestingly, a majority of T2D participants are apprehensive about “taking too much medication”. They believe consuming medications for an indefinite length of time could lead to permanent physical impairment.

“I have to take 7 pills in the morning, 7 in the afternoon and another 7 at night. That’s a total of 21 pills in a day. These pills can somehow ‘accumulate’ in your vital organs. It will eventually destroy your kidney and pancreas” (60, Male)

Stigma

T2D participants often classify themselves as a “sick person” and feel embarrassed for having contracted the disease. A few of them think they will be “discriminated” if others discover that they have diabetes. Thus, many T2D people choose to keep their diagnosis confidential.

“You should see at their reaction and the look on their faces. They think I am going to die tomorrow. And that affects me a lot. I want to disclose my diagnosis sometimes. But I have already seen the double standards in the way they treat me previously.” (42, Female)

These negative perceptions strongly affect the emotions and behaviour of these individuals at many different levels. For example, they avoid being seen while taking medications. Similarly, insulin users in our study feel depressed and worry about what others might think now that they have commenced using injectables. Interviews with pharmacists and diabetes educators reveal that these emotions trigger a certain uneasiness injecting insulin in the presence of others. Therefore, many participants who are insulin users frequently excuse themselves (preferring privacy) when administering insulin.

“I prefer to do it in private when I am alone in my room. Usually, I will wake up in the morning, shower and then I will use the insulin pen to inject myself.”(61, Male)

Unwarranted optimism

In the earlier stages of their disease, T2D participants hold a fervent belief that the disease can be cured and wonder why advancements in science have not brought about any permanent solution. In terms of dietary adherence, these individuals legitimize violations in food restrictions so long as they keep taking their medications in an orderly manner. They also downplay the seriousness of elevated blood glucose levels. This behaviour is further reinforced by the absence of any alarm symptoms after intentionally skipping their medications for several days.

“Because when I take my medications and inject insulin, I feel I am alright, therefore I can eat anything I want.” (48, Female)

“Doctors have warned me about the effects of high sugar levels in my body. But I didn’t take it too seriously initially. I only started worrying when I witnessed complications in other patients much later.” (28, Female)

“Sometimes, I don’t take my medication as suggested by the doctor. Because you see, when you have diabetes, you don’t feel anything even when if your sugar levels are elevated. You don’t feel a thing.” (60, Male)

Discussion

Summary of main findings

The findings from our study demonstrate the contrasting behavioural aspects that govern the internal psychological environment of people with T2D. The conceptual framework in Fig 1 implies that these attributes are insulated and function in a dichotomous manner. However, in reality, these behavioural attributes are mutually connected and certainly carry more merit than just the sum of its parts. As evidenced by the results of this study, these behavioural properties have a wide-ranging influence over the self-management practices of individuals with T2D and present a unique set of opportunities for focused intervention.

Two major themes were identified in relation to the cognitive reaction of participants with T2D to their disease, namely, 1) positive disposition and 2) negative disposition. Sub-categories within each theme can be further classified as constructive (positivity, optimism, vigilance, acceptance, coping mechanism, insight, awareness) and undesirable (denial, pessimism, reservations, stigma, worries, unwarranted optimism) behavioural factors. This distinctive classification makes it possible to realistically identify and cultivate more positive traits amongst people with T2D. In the long run, this step can negate the unproductive mindset seen in these individuals by 1) enabling greater personalization of pre-existing treatment strategies and 2) facilitating more sustainable self-management practices that are connected to their belief system.

Comparison with literature

The theoretical components obtained from this study enhance and build upon other well established behavioural models commonly utilized to explain the widely held beliefs and perceptions patients have about their illness [15]. For the most part, this belief system mirrors the 5 dimensions seen in the concept of illness cognitions [1517]. For instance, in our study, individuals with T2D shared detailed information about their relationship with their disease by recognizing the concepts of identity, consequences, controllability, and curability of T2D [15,17]. These perceptions evoke an emotional response (positive or negative disposition) in T2D people in our study. Most importantly, these reactions serve as a precursor in developing an appropriate coping strategy in relation to their disease. This chain of events is in line with Leventhal’s self-regulatory model [15]. Nevertheless, what seems lacking is an appraisal phase where individuals with T2D contemplate either persisting or choosing an alternative strategy to manage their disease.

Several categories found in this study share close parallels with the cognitive adaptation theory [15]. For example, participants with T2D have a clear understanding of the nature of their illness (awareness and reservations). They often ponder the impact T2D will have on their lives (acceptance, stigma, and worries). They also display elements of self-enhancement–participants with T2D embrace positive thoughts (optimism and positivity) that help boost self-esteem. Additionally, the illusory aspects of their thought processes were exemplified by an unwarranted optimism in how they cope with their disease. The equilibrium between the various shades of these personal attributes influences the state of self-mastery (central to the process of cognitive adaptation) in these individuals [15].

Strengths and limitations

This study depicts the summation of the various behavioural traits of the archetypal T2D people into a unified operational model. Although many separate attempts were made to describe patient self-management behaviour in Malaysia, we uniquely examined and condensed the overall behavioural attributes of individuals with T2D within a single practice-based qualitative study [1820]. Moreover, our findings widely correspond to the results seen in other T2D people assessed worldwide, which further substantiates the opinion that most T2D people share a common psychological profile in terms of self-management behaviour [2123].

Contrary to previous fragmentary descriptions of self-management practices in the form of systematic reviews or qualitative metanalysis [2123], our study consolidates the connections and interactions between these behavioural attributes of a typical T2D person found in a conventional clinical setting. While many of the themes presented in this study have been described elsewhere in literature [2123], our study collates these findings into a functional framework that defines the attributes of T2D people with regards to self-management practices (Fig 1). Moreover, we have classified the psychosocial challenges of individuals with T2D into operational codes by adhering to a stringent set of theory-building research techniques (S1 File, S1 Table). This initiative is in tandem with the recommendations from the DAWN2 study, which calls for the formulation of a distinct psychosocial approach that is specific to cultural sensitivities and societal norms [8].

Individuals with T2D in this study were recruited from only one regional primary care institution. However, the richness and quality of the data were established through methodological triangulation, where selected HCPs from adjacent clinics were interviewed to verify the views put forward by individuals with T2D. Additionally, we emphasized inclusivity by obtaining people with T2D 1) from a community-based setting and 2) with a mixed sociodemographic background.

Implications for future research and clinical practice

Our research initiative supports the need to transform naturalistic narratives derived from a qualitative inquiry into measurable scales that accurately reflect the behaviour intrinsic to the population that is being studied [24]. This carefully planned real-world evaluation, coupled with the subsequent process of interpretative deduction, has uncovered practical targets for behavioural change that can be easily integrated into routine clinical practice. This step (as opposed to standard care alone) could enable a more person-centered approach, leading to smoother behavioural transformation in people with T2D.

This study’s overarching objective is to create a realistic benchmark for self-management behaviour in T2D people from data that is acquired from a naturalistic environment [25]. Many pre-existing scales in literature have not been rigorously evaluated in terms of validity and reliability [25]. Furthermore, these inventories lack robust psychometric properties, rendering it challenging to detect any changes in self-care practices as a result of behavioural change intervention [25]. To that end, the creation of this operational model for self-management behaviour can ultimately generate a largely cohesive psychometric inventory explaining the many different shades of emotions that characterize the psyche of individuals with T2D.

Conclusions

An approach that prioritizes the needs of the patient (person-centered) rather than an exclusive focus on their “disease” alone could break the deadlock impeding optimal disease control in T2D people [5]. To that end, there is a window of opportunity for HCPs to first analyze the personality characteristics of T2D people as depicted in this study and subsequently formulate useful evidence-based psychological interventions [24, 26]. GP consultations guided by an awareness of these inherent strengths and weaknesses can help empower individuals with T2D to actively take charge of their disease [5, 27]. Furthermore, the behavioural constructs discovered in this study can be used to create a psychometric inventory to gauge the psychological polarity of T2D people in terms of their commitment towards self-management behaviour. This step would enable HCPs to implement and appraise the outcomes of a streamlined evidence-based intervention in many different clinical settings.

Supporting information

S1 File. Topic guides for in-depth interviews and focused group discussions.

(DOCX)

S1 Fig. Flow chart of the study design and development of conceptual framework.

(DOCX)

S1 Table. Themes, sub-themes, codes, quotations within the conceptual model (via grounded theory Approach).

(DOCX)

S2 Table. Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist.

(DOCX)

Acknowledgments

We are eternally grateful to all those extraordinary individuals at Monash University who continue to remind us about humility and compassion behind their random acts of kindness. We would also like to dedicate this article to Musonius Rufus, Seneca, Marcus Aurelius and Publius Syrus, whose works gave us the wisdom to condense the complexity of human emotions into legible words accessible to all.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This study was funded by the MOH-NIH grant (Grant No.:91000440) received from the Ministry of Health Malaysia. YSN was the recipient of this grant. URL to grant website (http://www.nih.gov.my/web/grant-application/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.International Diabetes Federation. IDF Atlas, 8th Edition. 2017. [cited 8 Jul 2018] pp. 1–145. Available: https://diabetesatlas.org/IDF_Diabetes_Atlas_8e_interactive_EN/ [Google Scholar]
  • 2.Zimmet P. Diabetes and its drivers: the largest epidemic in human history? Clin Diabetes Endocrinol. 2017;3: 1. 10.1186/s40842-016-0039-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cho NH, Shaw JE, Karuranga S, Huang Y, Rocha JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138: 271–281. 10.1016/j.diabres.2018.02.023 [DOI] [PubMed] [Google Scholar]
  • 4.Wild S, Roglic C, Green A, Sicree R, King H. Global prevalence of diabetes—Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27: 1047–1053. 10.2337/diacare.27.5.1047 [DOI] [PubMed] [Google Scholar]
  • 5.Serrano-Gil M, Jacob S. Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude and practice gap? Adv Ther. 2010;27: 321–333. 10.1007/s12325-010-0034-5 [DOI] [PubMed] [Google Scholar]
  • 6.Monnier L, Colette C, Owens DR. Type 2 diabetes: a well-characterised but suboptimally controlled disease. Can we bridge the divide? Diabetes Metab. 2008;34: 207–216. 10.1016/j.diabet.2008.01.011 [DOI] [PubMed] [Google Scholar]
  • 7.Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414: 782–787. 10.1038/414782a [DOI] [PubMed] [Google Scholar]
  • 8.Bootle S, Skovlund SE. Proceedings of the 5th International DAWN Summit 2014: Acting together to make person-centred diabetes care a reality. Diabetes Res Clin Pract. 2015;109: 6–18. 10.1016/j.diabres.2015.04.004 [DOI] [PubMed] [Google Scholar]
  • 9.Holt RIG, Nicolucci A, Kovacs Burns K, Lucisano G, Skovlund SE, Forbes A, et al. Correlates of psychological care strategies for people with diabetes in the second Diabetes Attitudes, Wishes and Needs (DAWN2TM) study. Diabet Med. 2016;33: 1174–1183. 10.1111/dme.13109 [DOI] [PubMed] [Google Scholar]
  • 10.Kovacs Burns K, Holt RIG, Nicolucci A, Lucisano G, Skovlund SE, Comaschi M, et al. Correlates of psychological outcomes among family members of people with diabetes in the second Diabetes Attitudes, Wishes and Needs (DAWN2TM) study. Diabet Med. 2016;33: 1184–1193. 10.1111/dme.13136 [DOI] [PubMed] [Google Scholar]
  • 11.Swarna Nantha Y, Haque S, Swarna Nantha H. The development of an integrated behavioural model of patient compliance with diabetes medication: a mixed-method study protocol. Fam Pr. 2018; 1–6. 10.1093/fampra/cmy119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Charmaz K. Constructing Grounded Theory—A Practical Guide through Qualitative Analysis. 1st ed. London: SAGE Publications Ltd.; 2006. [Google Scholar]
  • 13.Corbin J, Strauss A. Basics of qualitative research: Techniques and procedures for developing grounded theory. 4th ed. California: SAGE; 2015. [Google Scholar]
  • 14.Brien BCO, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for Reporting Qualitative Research: 2014;89: 1245–1251. 10.1097/ACM.0000000000000388 [DOI] [PubMed] [Google Scholar]
  • 15.Ogden J. Health psychology—a textbook. 2012th ed. Berkshire: Open University Press; 2012. [Google Scholar]
  • 16.Harvey JN, Lawson VL. The importance of health belief models in determining self-care behaviour in diabetes. Diabet Med. 2009;26: 5–13. 10.1111/j.1464-5491.2008.02628.x [DOI] [PubMed] [Google Scholar]
  • 17.Marks DF, Murray M, Evanss B, Estacio EM. Health Psychology—Theory, research and practice. 4th ed. London: SAGE Publications Ltd.; 2014. [Google Scholar]
  • 18.Hussein Z, Taher SW, Gilcharan Singh HK, Chee Siew Swee W. Diabetes Care in Malaysia: Problems, New Models, and Solutions. Ann Glob Heal. 2015;81: 851–862. 10.1016/j.aogh.2015.12.016 [DOI] [PubMed] [Google Scholar]
  • 19.Low LL, Tong SF, Low WY. Selection of treatment strategies among patients with Type 2 Diabetes Mellitus in Malaysia: A Grounded Theory approach. PLoS One. 2016;11: 1–15. 10.1371/journal.pone.0147127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Low LL, Tong SF, Low WY. Mixed Feelings about the Diagnosis of Type 2 Diabetes Mellitus: A Consequence of Adjusting To Health Related Quality Of Life Lee. Coll Antropol. 2014;38: 11–20. 10.1111/obr.12258.Appetite [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Beverly EA, Ritholz MD, Brooks KM, Hultgren BA, Lee Y, Abrahamson MJ, et al. A qualitative study of perceived responsibility and self-blame in type 2 diabetes: Reflections of physicians and patients. J Gen Intern Med. 2012;27: 1180–1187. 10.1007/s11606-012-2070-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Newton P, Asimakopoulou K, Scambler S. A qualitative exploration of motivation to self-manage and styles of self-management amongst people living with type 2 diabetes. J Diabetes Res. 2015;2015. 10.1155/2015/638205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Rushforth B, McCrorie C, Glidewell L, Midgley E, Foy R. Barriers to effective management of type 2 diabetes in primary care: Qualitative systematic review. Br J Gen Pract. 2016;66: e114–e127. 10.3399/bjgp16X683509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in management of diabetes mellitus. J Diabetes Matabolic Disord. 2013;12: 14. 10.1186/2251-6581-12-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lu Y, Xu J, Zhao W, Han HR. Measuring Self-Care in Persons With Type 2 Diabetes: A Systematic Review. Eval Heal Prof. 2016;39: 131–184. 10.1177/0163278715588927 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ockleford E, Shaw RL, Willars J, Dixon-Woods M. Education and self-management for people newly diagnosed with type 2 diabetes: a qualitative study of patients’ views. Chronic Illn. 2008;4: 28–37. 10.1177/1742395307086673 [DOI] [PubMed] [Google Scholar]
  • 27.Anderson MA, Funell MM. Using the empowerment approach to help patients change behaviour. 2nd ed. In: Anderson BJ, Rubin RR, editor. Practical Psychology for diabetes clinicians. 2nd ed. Alexandria: American Diabetes Association; 2002. pp. 1–255. [Google Scholar]

Decision Letter 0

Nelly Oelke

5 Feb 2021

PONE-D-19-33966

The internal realities of individuals with type 2 diabetes  – understanding personal disposition towards disease management via Grounded Theory approach

PLOS ONE

Dear Dr. Swarna Nantha,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Nelly Oelke

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please address the following:

- Please include additional information regarding the survey or interview guide used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. In addition, please include further information concerning the development and/or pre-testing of this guide.

- Please provide the dates of patient recruitment to this study.

3. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

4. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately.  These will be automatically included in the reviewers’ PDF.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Additional Editor Comments:

Thank you for your resubmission of your manuscript. I have reviewed the reviewer comments and provide some additional comments for your manuscript. These are listed below. Please ensure that you provide a track-changed document in re-submitting your manuscript.

Specific comments:

Page 2, Line 6: In the abstract, “dimension” should be pluralized to “dimensions”

Page 2, Line 7: In the abstract, “T2D patient” also needs to be plural, “patients”

Page 2, Lines 16/17: Would recommend rephrasing the sentence so it does not start with a number. Perhaps something like this: “To examine the inner narratives about disease management and what they believe about the disease, 24 T2D patients and 10 healthcare professionals were recruited.”

Page 2, Line 25: In the abstract results section, “to disease management” should be changed to “for disease…”

Page 3, Lines 6/7: “2 folds” should be “2-fold” singular.

Page 3, Line 13: HCP should be plural (HCPs) when referring to more than one HCP.

Continued minor edits (e.g., plural vs singular, missing words, extra words) evident and need to be addressed.

Introduction:

Page 3, Lines 26-28: Would suggest not talking about publishing the procedures, but the aim of the paper is sharing the results related to…using the protocol previously published (11).

Page 3, Line 28: Grounded should not be capitalized.

Methods:

Pages 5-6, Tables 1 and 2: I am concerned about the confidentiality of data when there are cells that have less than 5 participants. These may be identifiable. Please revise, could use <5 for those cells, or report in more broad categories.

Page 7, Line 5: This paper uses a lot of abbreviations and acronyms. I would suggest not abbreviating in-depth interviews and removing the IDI abbreviation. It is not commonly used. Please attend to these revisions throughout the paper.

Data Collection and Analysis:

Reviewer 2 suggests adding information on constant comparative analysis as this is key to grounded theory. I would agree, as it currently stands, your methods could easily reflect a descriptive qualitative study.

Discussion:

The discussion section is very short and provides only a summary of the results as it currently appears. I would put the “comparison to literature” section after the discussion summary, or perhaps amalgamate these sections and then present strengths and limitations. Authors also need to discuss the impacts/relevancy for policy and practice. What is needed is the “So what?”

Strengths and Limitations:

Some of the information included here may be able to be highlighted/moved to the discussion section.

I also find that all of the results are heavily focused on medications and use of the same. Self-management is a much bigger topic than only medications. It should include eating habits/nutrition, exercise, and mental health and wellbeing, the latter which is addressed somewhat. I would encourage that if there is data, to more fully report the results. If there is no data, perhaps this is a study of self-management of medications and some of the wording and title may need to reflect that. You may also want to delineate this as a limitation in your limitations section.

References:

Reviewer 1 discusses the need for more updated references. I would agree that some of the references are fairly old, particularly those that provide statistics, or other components of self-management. We do understand that there are some seminal references, particularly around analysis and design. Please review and revise the references accordingly.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I have gone through your document and I got it very good and sound able. I strongly suggest you the authors collect and then aggregate comments I have mentioned on the recommendation paper. Hoping you are proofreading the document so that a lot of grammatic and spelling disorganizations are modified.

Reviewer #2: This is an excellent qualitative research done by grounded theory. based on the data in their hand, the authors explained the relationship between self-management practices of Type 2 Diabetic patients and the inner psychological dispositions that affect the practice. One of the main strengths of this study is that it included variety of data sources to get full explanation of issues for all people in the given context. Participants and their recruitment process are well explained and appropriate to the study. The authors clearly described the data collection process, including recording and they collected the data using variety of qualitative techniques, which is very essential when it comes to grounded theory. The authors were responsive to most of the previous reviewers’ feedback. Overall, the methods, interpretation, and communication of the findings are relevant and reasonable.

Major comments

1, even though the authors adequately explained which purposive sampling technique did they used, they did not mention anything about which criteria/rule of saturation have they used; in order to know when to stop further data collection and start to count the number of people who had participated and eventually know the final sample size. Hence, I would like to ask the authors when was the point where they feel reasonably confident that they have saturated a particular source of information to the point of redundancy or when was the point where they feel that the incoming data have adequately answered their research questions?

2, page 7, line 4--> “… Ultimately, 24 patients and 10 HCPs took part in in-depth interviews (IDI) conducted between…”

-->the stated data collection technique that the authors used for the 10 HCPs should not be named an ‘in-depth interview’. Because, the HCPs were not being interviewed about themselves (they are not a diabetic patients). In-depth interview is all about the participants themselves. Therefore, I would recommend it be changed to a ‘key informant interview’, as they have been interviewed only because of their position or due to the fact that they are well aware about the disease instead of being patients.

3, I wonder how the authors decided on how many focus groups to form? it is generally recommended to conduct at least two FGDs for a certain defining demographic variable. Was it conducted based on gender? Having complication or not? any other variables? Or by simply dividing the number of patients in to two randomly?

4, on the data collection, data management, and analysis section, I recommend mentioning the use of constant comparative analysis. As the research is done via grounded theory, it is basically expected to do simultaneous collection and analysis of the data.

Minor comments

1. I share a comment made by a previous reviewer which is

“There is no full form of the abbreviation “IDM” in the verbatim. The verbatim needs to be given demographic details like for example: “35-year-old T2D, self-employed male, FGD participant””.

However, I could not find this change in the post comment Manuscript Draft. I apologize if I missed this or if I am having the pre comment Manuscript Draft. Can the authors please double check to confirm they included this information?

2. page 9, line 14--> this should be “…indicates that most…” rather than “…indicate that most...”

3. page 11, Line 11--> Remove “the” before “… taking medication in accordance….”

4. page 11, Line 26--> add “of” after “… People with diabetes recognize the importance….”

5. page 19, line 4--> there is no space between two the words “….implementand appraise…”

6. page 7, line 4--> This should be “….in the in-depth interviews (IDI) conducted…” rather than “…in in-depth interviews (IDI) conducted….”

Thank you,

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dejene Tsegaye Alem

Reviewer #2: Yes: Meron Asmamaw Alemayehu

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Comments.docx

PLoS One. 2021 Apr 13;16(4):e0249620. doi: 10.1371/journal.pone.0249620.r003

Author response to Decision Letter 0


15 Feb 2021

We would like to thank all reviewers for examining our manuscript and providing insightful comments. We have responded to each your comments in the "Response to Reviewers" file.

Attachment

Submitted filename: Response To Reviewers (7.2.2021).docx

Decision Letter 1

Nelly Oelke

23 Feb 2021

PONE-D-19-33966R1

The Internal Realities of Individuals with Type 2 Diabetes – Psychological Disposition in Self-Management Behaviour via Grounded Theory Approach

PLOS ONE

Dear Dr. Yogarabindranath Swarna Nantha,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Thank you for submitting your revised manuscript. We have reviewed the same and require revisions as requested below. All of revisions should be addressed and submitted using track changes and line numbers in the manuscript. We look forward to receiving your revised manuscript. 

Please submit your revised manuscript by April 22, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Nelly Oelke

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Thank you for submitting your revised manuscript. The revised manuscript has been reviewed and we would ask that you make additional revisions to the manuscript based on the following suggestions:

1. There are many lines in the manuscript that only have a word or two. The formatting needs to be adjusted.

2. There are many specific comments that still require they be addressed. They are listed as follows:

• Short title in your manuscript still does not match that in the introductory form

• Page 2, second and ninth lines, results section, and conclusion section of the abstract please spell out type 2 diabetes or consistently use the abbreviation.

• Page 2, methods in abstract should say “a” grounded theory approach instead of “the.” Also would suggest not capitalizing grounded theory.

• Page 2, second line of methods in abstract remove T2D

• Page 2, last line of results should read motivational “and” follow through

• Page 4, second line under design has an extra bracket in the middle of the line.

• Page 4, 3rd line in the design section would consider using “individuals” instead of people.

• Page 4, suggest changing “good spread” to diverse sample.

• Page 5, Line 6, “comprising” should be changed to “comprised”

• Tables 1 and 2 still have some cells with less than 5 participants (e.g., ethnicity – Chinese – 1) Please revise accordingly.

• Page 7, top of the page, numbers reported on number of participants should go before Tables and with the demographic data.

• Bottom of page 7, “remain” needs to be “remained”

• Bottom of page 7, top of page 8: the topic guide you have already talked about and referenced as reference 11. Suggest adding the interview technique above as well so this isn’t repeated.

• Text at bottom of page 7 and top of page 8 is in a different font.

• Page 8 – why were two qualitative software packages used?

• Page 8 – analysis still does not contain a lot of information on grounded theory approach (e.g., constant comparative analysis).

• Page 8 – not sure if trustworthiness can be made certain; it can certainly be enhanced and facilitated.

• Results section – you have changed much of language to people with T2D. This is a generalization and your results only apply to your participants. You will need to address and make appropriate changes.

• Page 12 – two thirds of the way down, “only during at the initial phases of their disease.” This phrase needs to be revised.

• Page 13, first paragraph, “They believe that it is necessary to consume medications lifelong…” Reword as “They believe that it is necessary for lifelong medications…” for clarity and flow.

• Page 15, second last paragraph, “appear” should be “appears.”

• Page 21, paragraph two, “we emphasized on inclusivity…”, remove “on.”

• Acknowledgements should have the “e’ in the word. Please replace the same.

3. In addition to using track changes on your the next revised version of the manuscript, please use line numbers in the document.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Nelly Oelke

16 Mar 2021

PONE-D-19-33966R2

The Internal Realities of Individuals with Type 2 Diabetes – Psychological Disposition in Self-Management Behaviour via Grounded Theory Approach

PLOS ONE

Dear Dr. Yogarabindranath Swarna Nantha,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Thank you for resubmitting your revised manuscript. Please address all comments below. 

Please submit your revised manuscript by May 7, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Nelly Oelke

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Thank you for the re-submission of your manuscript and attending to many of the requirements of the reviews. There are still a few issues that need to be addressed.

1. Response and actions, if appropriate, to the comment re: retracted references.

2. Tables 1 and 2 still have cells with less than 5 participants. Please review and mark all those that are under 5 as <5.

3. There are still some areas with extra space and lines. Please remove and ensure your manuscript is consistent throughout. Also there are still a few lines that have only a few words and then go to the next line. Please remove the same.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Apr 13;16(4):e0249620. doi: 10.1371/journal.pone.0249620.r007

Author response to Decision Letter 2


16 Mar 2021

We would like to thank the PLOS One for an excellent peer review and editorial process. We apologize for not being thorough with our previous revision process. In this current submission, we have taken every step possible to ensure that all comments have been addressed as described in the Response to Reviewer document. Please let us know if additional revisions are required.

Attachment

Submitted filename: Response To Reviewers (17.3.2021).docx

Decision Letter 3

Nelly Oelke

23 Mar 2021

The Internal Realities of Individuals with Type 2 Diabetes – Psychological Disposition in Self-Management Behaviour via Grounded Theory Approach

PONE-D-19-33966R3

Dear Dr. Yogarabindranath Swarna Nantha,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nelly Oelke

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Nelly Oelke

25 Mar 2021

PONE-D-19-33966R3

The Internal Realities of Individuals with Type 2 Diabetes – Psychological Disposition in Self-Management Behaviour via Grounded Theory Approach

Dear Dr. Swarna Nantha:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nelly Oelke

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Topic guides for in-depth interviews and focused group discussions.

    (DOCX)

    S1 Fig. Flow chart of the study design and development of conceptual framework.

    (DOCX)

    S1 Table. Themes, sub-themes, codes, quotations within the conceptual model (via grounded theory Approach).

    (DOCX)

    S2 Table. Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist.

    (DOCX)

    Attachment

    Submitted filename: Response To Reviewers.docx

    Attachment

    Submitted filename: Comments.docx

    Attachment

    Submitted filename: Response To Reviewers (7.2.2021).docx

    Attachment

    Submitted filename: Response To Reviewers (27.2.2021).docx

    Attachment

    Submitted filename: Response To Reviewers (17.3.2021).docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES